Market Price

357.94 

-8.22 -2.2%

as of Aug 23 '19

52 Week Range:

226.02 373.90


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Oct '17 Dec '18
Equity (BVPS) 31.39
39.75
44.59
47.43
43.42
45.17
47.82
46.60
49.23
54.74
54.48
growth rate 26.6% 12.2% 6.4% -8.5% 4.0% 5.9% -2.6% 5.6% 11.2% -0.5%
Earnings BIT 220.98
182.85
147.79
148.70
-165.37
175.73
300.21
328.23
376.37
405.09
487.92
growth rate -17.3% -19.2% 0.6% -100.0% 100.0% 70.8% 9.3% 14.7% 7.6% 20.5%
Avg.PE 14.90
15.17
17.42
20.70
-14.30
27.10
30.11
35.67
38.08
77.57
196.30
growth rate 1.8% 14.8% 18.8% -100.0% 100.0% 11.1% 18.5% 6.8% 103.7% 153.1%
ROA 2.95
7.80
5.38
8.55
-4.96
3.80
4.59
6.23
6.11
3.03
3.22
growth rate 164.4% -31.0% 58.9% -100.0% 100.0% 20.8% 35.7% -1.9% -50.4% 6.3%
ROE 9.30
21.44
11.96
17.18
-10.11
8.17
9.81
12.49
11.44
6.68
8.08
growth rate 130.5% -44.2% 43.7% -100.0% 100.0% 20.1% 27.3% -8.4% -41.6% 21.0%
ROIC 7.26
13.32
9.81
13.47
-4.05
6.71
7.90
10.03
9.28
5.02
6.23
growth rate 83.5% -26.4% 37.3% -100.0% 100.0% 17.7% 27.0% -7.5% -45.9% 24.1%
Cur. Ratio 1.82
2.98
2.19
4.72
3.89
1.89
1.66
1.51
2.77
2.33
2.12
growth rate 63.7% -26.5% 115.5% -17.6% -51.4% -12.2% -9.0% 83.4% -15.9% -9.0%
Quick Ratio 0.83
1.64
1.20
3.21
2.31
1.15
0.91
0.90
1.91
1.40
1.24
growth rate 97.6% -26.8% 167.5% -28.0% -50.2% -20.9% -1.1% 112.2% -26.7% -11.4%
Leverage 3.15
2.43
2.04
1.98
2.10
2.20
2.08
1.93
1.82
2.54
2.47
growth rate -22.9% -16.1% -2.9% 6.1% 4.8% -5.5% -7.2% -5.7% 39.6% -2.8%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Oct '17 Dec '18
Acct.Receivable 311.90
265.30
294.20
327.24
349.00
348.21
273.70
262.42
271.99
345.88
366.29
growth rate -14.9% 10.9% 11.2% 6.7% -0.2% -21.4% -4.1% 3.7% 27.2% 5.9%
Acct.Payable 238.78
241.13
252.47
64.10
66.31
69.40
92.03
106.71
growth rate 1.0% 4.7% -74.6% 3.4% 4.7% 32.6% 16.0%
Cur.Assets 957.40
1,003.90
921.20
1,280.26
1,073.22
1,200.55
995.91
1,003.84
1,183.39
1,128.81
1,236.17
growth rate 4.9% -8.2% 39.0% -16.2% 11.9% -17.1% 0.8% 17.9% -4.6% 9.5%
Total Assets 3,926.70
3,839.00
3,643.20
3,924.10
3,733.69
4,209.01
3,922.79
3,871.77
3,891.21
6,181.49
6,277.99
growth rate -2.2% -5.1% 7.7% -4.9% 12.7% -6.8% -1.3% 0.5% 58.9% 1.6%
Cash 107.30
188.30
208.50
584.09
337.04
431.98
303.24
338.37
543.79
333.56
357.16
growth rate 75.5% 10.7% 180.1% -42.3% 28.2% -29.8% 11.6% 60.7% -38.7% 7.1%
Inventory 424.70
360.80
338.60
298.78
323.35
333.62
335.59
330.28
316.17
395.74
427.78
growth rate -15.1% -6.2% -11.8% 8.2% 3.2% 0.6% -1.6% -4.3% 25.2% 8.1%
Cur.Liabilities 525.90
337.10
420.80
271.01
275.30
635.12
632.77
664.12
427.65
483.88
582.46
growth rate -35.9% 24.8% -35.6% 1.6% 130.7% -0.4% 5.0% -35.6% 13.2% 20.4%
Liabilities 2,680.30
2,258.80
1,859.80
1,943.52
1,954.74
2,295.48
2,009.09
1,860.68
1,753.70
3,750.96
3,738.01
growth rate -15.7% -17.7% 4.5% 0.6% 17.4% -12.5% -7.4% -5.8% 113.9% -0.4%
LT Debt 1,437.50
1,192.50
813.40
954.81
965.28
930.00
700.00
641.85
850.25
2,162.93
2,079.99
growth rate -17.0% -31.8% 17.4% 1.1% -3.7% -24.7% -8.3% 32.5% 154.4% -3.8%
Equity 1,246.50
1,580.20
1,783.40
1,980.59
1,778.95
1,913.53
1,911.31
2,009.27
2,137.52
2,430.53
2,539.98
growth rate 26.8% 12.9% 11.1% -10.2% 7.6% -0.1% 5.1% 6.4% 13.7% 4.5%
Common Shares 40.00
40.00
40.00
41.00
41.00
44.00
46.00
48.00
48.00
47.00
47.00
growth rate 0.0% 0.0% 2.5% 0.0% 7.3% 4.6% 4.4% 0.0% -2.1% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Oct '17 Dec '18
Capital Expenditures 35.20
28.70
30.00
44.58
65.39
63.58
67.57
61.45
53.14
70.90
80.80
growth rate -18.5% 4.5% 48.6% 46.7% -2.8% 6.3% -9.1% -13.5% 33.4% 14.0%
Cash Dividends 53.00
54.00
55.50
55.14
55.59
55.92
56.26
56.53
58.96
61.24
62.17
growth rate 1.9% 2.8% -0.7% 0.8% 0.6% 0.6% 0.5% 4.3% 3.9% 1.5%
Cash From OA 171.20
204.20
213.10
94.36
194.62
231.30
286.57
300.81
408.48
419.89
437.38
growth rate 19.3% 4.4% -55.7% 106.3% 18.9% 23.9% 5.0% 35.8% 2.8% 4.2%
FCF per Share 3.31
4.35
4.46
2.89
2.95
2.61
5.28
3.97
7.81
7.60
7.08
growth rate 31.4% 2.5% -35.2% 2.1% -11.5% 102.3% -24.8% 96.7% -2.7% -6.8%
Sale Purchase of Stock 34.01
8.24
5.45
4.25
4.99
9.07
5.57
growth rate -75.8% -33.9% -22.0% 17.6% 81.6% -38.6%
FCF 132.00
174.00
180.00
49.00
121.00
163.00
219.00
239.00
355.00
349.00
357.00
growth rate 31.8% 3.5% -72.8% 146.9% 34.7% 34.4% 9.1% 48.5% -1.7% 2.3%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Oct '17 Dec '18
Sales 2,066.70
1,766.30
1,433.30
1,492.53
1,551.01
1,696.27
1,827.13
1,799.49
1,868.03
2,146.30
2,448.38
growth rate -14.5% -18.9% 4.1% 3.9% 9.4% 7.7% -1.5% 3.8% 14.9% 14.1%
Op.Income 265.00
256.90
233.40
119.32
-181.78
152.18
300.21
328.23
376.37
405.09
487.92
growth rate -3.1% -9.2% -48.9% -100.0% 100.0% 97.3% 9.3% 14.7% 7.6% 20.5%
IBT 145.60
169.90
107.70
145.10
-165.37
175.73
220.11
244.65
245.73
284.91
219.63
growth rate 16.7% -36.6% 34.7% -100.0% 100.0% 25.3% 11.2% 0.4% 16.0% -22.9%
Net Income 119.80
303.00
201.10
119.32
-181.78
152.18
187.68
244.86
237.38
152.53
200.80
growth rate 152.9% -33.6% -40.7% -100.0% 100.0% 23.3% 30.5% -3.1% -35.7% 31.7%
EPS 3.01
7.59
4.99
7.92
-4.65
3.45
4.04
5.10
4.98
3.27
4.29
growth rate 152.2% -34.3% 58.7% -100.0% 100.0% 17.1% 26.2% -2.4% -34.3% 31.2%
Gross Profit 855.00
772.20
688.50
708.78
748.23
838.95
947.33
953.90
1,004.70
1,186.24
1,419.84
growth rate -9.7% -10.8% 3.0% 5.6% 12.1% 12.9% 0.7% 5.3% 18.1% 19.7%
R&D 36.70
42.60
48.71
56.28
65.05
61.04
52.12
58.58
84.77
106.21
growth rate 16.1% 14.4% 15.5% 15.6% -6.2% -14.6% 12.4% 44.7% 25.3%

Quarterly Statements

Item Name Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Earnings BIT 101.30
103.11
157.72
104.16
109.14
growth rate 1.8% 53.0% -34.0% 4.8%
Balance Sheet Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 359.14
374.34
366.29
375.76
382.14
growth rate 4.2% -2.2% 2.6% 1.7%
Acct.Payable 84.69
97.63
106.71
103.53
108.06
growth rate 15.3% 9.3% -3.0% 4.4%
Cur.Assets 1,205.16
1,240.81
1,236.17
1,182.61
1,245.14
growth rate 3.0% -0.4% -4.3% 5.3%
Total Assets 6,300.60
6,200.72
6,277.99
6,268.07
6,314.41
growth rate -1.6% 1.3% -0.2% 0.7%
Cash 378.87
356.28
357.16
271.21
303.90
growth rate -6.0% 0.3% -24.1% 12.1%
Inventory 403.68
411.07
427.78
445.57
461.32
growth rate 1.8% 4.1% 4.2% 3.5%
Cur.Liabilities 551.77
549.29
582.46
520.92
493.89
growth rate -0.5% 6.0% -10.6% -5.2%
Liabilities 3,740.10
3,693.66
3,738.01
3,698.19
3,649.57
growth rate -1.2% 1.2% -1.1% -1.3%
LT Debt 2,154.22
2,075.83
2,079.99
2,076.65
2,081.37
growth rate -3.6% 0.2% -0.2% 0.2%
Equity 2,560.50
2,507.07
2,539.98
2,569.88
2,664.84
growth rate -2.1% 1.3% 1.2% 3.7%
Common Shares 46.97
47.19
47.25
47.32
2,664.84
growth rate 0.5% 0.1% 0.2% 5,531.2%
Cash Flow Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 15.75
17.75
25.04
23.49
32.61
growth rate 12.7% 41.1% -6.2% 38.8%
Cash Dividends 15.45
15.59
15.64
15.65
growth rate 0.9% 0.3% 0.1%
Cash From OA 86.64
121.12
135.14
63.78
96.31
growth rate 39.8% 11.6% -52.8% 51.0%
Sale Purchase of Stock 1.40
8.40
growth rate 500.0%
FCF 70.90
103.38
110.09
40.28
63.69
growth rate 45.8% 6.5% -63.4% 58.1%
Income Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Sales 587.23
609.67
641.62
613.58
652.51
growth rate 3.8% 5.2% -4.4% 6.3%
Op.Income 101.30
103.11
157.72
104.16
109.14
growth rate 1.8% 53.0% -34.0% 4.8%
IBT 61.17
55.25
96.18
52.89
87.17
growth rate -9.7% 74.1% -45.0% 64.8%
Net Income 56.18
56.52
90.59
40.90
83.38
growth rate 0.6% 60.3% -54.9% 103.9%
EPS
growth rate
Gross Profit 333.07
344.37
398.42
345.94
372.92
growth rate 3.4% 15.7% -13.2% 7.8%
R&D 26.03
26.37
27.80
27.15
27.60
growth rate 1.3% 5.4% -2.3% 1.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (53.59)

YOY Growth Grade:

D (46.45)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 69.97 83.38 23.58
EPS / Growth 14.7% 4.29 16.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.2% 12.4% 12.4%
Future PE 12.38 24.18 24.18
Future EPS 7.83 13.81 13.81
Value Price
MOS %
23.95
-93.3%
82.51
-77.0%
82.51
-77.0%
MOS Price 11.98 41.25 41.25
IRT 29.43 19.87 19.87

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.